• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 11-Aug-2022 EOD, Market Closed
SENSEX
59,332.60
515.31 (0.88%)
NIFTY
17,659.00
124.25 (0.71%)
    No Companies Visited

Back to news list
  • Alkem Lab Q1 PAT slumps 72% YoY to Rs 131 cr

    Alkem Laboratories' consolidated net profit declined 72.62% to Rs 131.45 crore on 5.7% decline in revenue from operations to Rs 2,576.38 crore in Q1 FY23 over Q1 FY22.

    Profit before tax slumped 72.68% year on year to Rs 151.89 crore in the quarter ended 30 June 2022. The company's India sales were at Rs 1,781.5 crore (up 6.7% YoY) while Int...Profit before tax slumped 72.68% year on year to Rs 151.89 crore in the quarter ended 30 June 2022. The company's India sales were at Rs 1,781.5 crore (up 6.7% YoY) while International sales were at Rs 760.4 crore (down 3.8% YoY) in the first quarter. EBITDA declined 65.7% YoY to Rs 203.2 crore in Q1 FY23. EBITDA margin was at 7.9% as on 30 June 2022 as against 21.7% as on 30 June 2021. R&D expenses for the quarter was Rs 132 crore, or 5.1% of total revenue from operations compared to Rs 118.3 crore in Q1 FY22 at 4.3% of total revenue from operations.

    During the quarter, the company filed 3 abbreviated new drug applications (ANDAs) with the US FDA and received 4 approvals (including 1 tentative approval).

    As on 30 June 2022, the company filed a total of 164 ANDAs and 2 new drug applications (NDA) with the USFDA. Of these, it has received approvals for 124 ANDAs (including 13 tentative approvals) and 2 NDAs.

    Sandeep Singh, managing director of Alkem, said, “We are starting the new fiscal year on a positive note, with yet another market beating performance in domestic market adjusting for huge base of last year [CAGR of 13.4%, Q1FY20-Q1FY23]. However, headwinds from price erosion in US market and inflationary environment has impacted margins for the quarter. As we move ahead, we remain focused on our journey of expanding margins through productivity improvement and various cost optimization initiatives across the organization. Our biosimilar franchise is shaping up well and we are looking forward to some exciting launches going ahead.”

    Alkem is a pharmaceutical company with global operations. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

    The scrip fell 0.47% to currently trade at Rs 3,137.95 on the BSE.



    Back to news list
Previous Stories :
More






Hot Pursuit News

Quick Links

Market Statistics

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
9769005430
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 11-Aug-2022
  •  ( 14:33) Nifty hovers above 17,650; Fin. services shares rises  
  •  ( 13:37) Sensex spurts 455 pts, European shares advance  
  •  ( 13:19) PB Fintech net loss widens to Rs 204 crore in Q1  
  •  ( 13:02) Radico Khaitan Q1 PAT decline 3% YoY to Rs 58 cr  
  •  ( 12:21) Abbott India Q1 PAT rises 5% YoY to Rs 205 cr  
  •  ( 11:57) Oil India Q1 PAT soars to Rs 1,555 cr  
  •  ( 11:34) Indices trade with strong gains; Nifty hovers at 17,650  
  •  ( 10:58) Patanjali Foods Q1 PAT jumps 39% YoY to Rs 241 cr  
  •  ( 10:34) Barometers turn range bound; Nifty hovers above 17,650  
  •  ( 10:08) Coal India Q1 PAT zooms 179% to Rs 8,833 cr  
  •  ( 10:01) Mazagon Dock Q1 PAT soars 121% YoY to Rs 225 cr  
  •  ( 09:34) Indices open on firm note; Nifty above 17,650  
  •  ( 09:25) Market breadth was strong  
  •  ( 09:19) HEG Q1 PAT spurts 180% YoY to Rs 159 cr  
  •  ( 08:36) Asian stocks trading higher  
  •  ( 08:25) Wall Street soars as inflation falls more than expected in July  
  •  ( 07:53) Wipro launches cybersecurity offering for Australian govt  
Show News
11 August 2022 00:00
3404.90
(-0.22 %)
759.20
(2.75 %)
7316.25
(2.36 %)
15729.30
(0.55 %)
709.55
(-0.76 %)
4257.15
(0.35 %)
2453.60
(2.32 %)
962.05
(1.00 %)
1486.75
(1.42 %)
2612.35
(-1.04 %)
859.30
(1.27 %)
1078.95
(1.60 %)
1619.70
(1.14 %)
306.30
(-1.56 %)
1854.15
(1.46 %)
1867.25
(0.68 %)
1265.55
(-0.15 %)
8818.00
(-0.69 %)
19688.45
(-0.39 %)
153.55
(-1.38 %)
222.80
(-0.25 %)
2590.20
(0.32 %)
524.55
(1.95 %)
920.00
(0.07 %)
109.10
(-0.14 %)
3422.45
(1.98 %)
1077.15
(2.12 %)
2471.60
(1.63 %)
6595.35
(0.06 %)
438.40
(1.93 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.